These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 14706261)

  • 41. Development of injection moulded matrix tablets based on mixtures of ethylcellulose and low-substituted hydroxypropylcellulose.
    Quinten T; Gonnissen Y; Adriaens E; De Beer T; Cnudde V; Masschaele B; Van Hoorebeke L; Siepmann J; Remon JP; Vervaet C
    Eur J Pharm Sci; 2009 Jun; 37(3-4):207-16. PubMed ID: 19491007
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Percolative drug diffusion from cylindrical matrix systems with unsealed boundaries.
    Brohede U; Valizadeh S; Strømme M; Frenning G
    J Pharm Sci; 2007 Nov; 96(11):3087-99. PubMed ID: 17721939
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Physicochemical properties and mechanisms of drug release from melt-extruded granules consisting of chlorpheniramine maleate and Eudragit FS.
    Zhang F
    Drug Dev Ind Pharm; 2016; 42(4):563-71. PubMed ID: 26065535
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characterization of thermal and rheological properties of zidovudine, lamivudine and plasticizer blends with ethyl cellulose to assess their suitability for hot melt extrusion.
    Maru SM; de Matas M; Kelly A; Paradkar A
    Eur J Pharm Sci; 2011 Nov; 44(4):471-8. PubMed ID: 21925600
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Development and in vitro evaluation of oral controlled release formulations of celecoxib using optimization techniques.
    Chandran S; Ravi P; Saha RN
    Yakugaku Zasshi; 2006 Jul; 126(7):505-14. PubMed ID: 16819273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Citric acid as a solid-state plasticizer for Eudragit RS PO.
    Schilling SU; Shah NH; Malick AW; Infeld MH; McGinity JW
    J Pharm Pharmacol; 2007 Nov; 59(11):1493-500. PubMed ID: 17976259
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microencapsulation of a hydrophilic drug into a hydrophobic matrix using a salting-out procedure. II. Effects of adsorbents on microsphere properties.
    Mani N; Suh HR; Jun HW
    Drug Dev Ind Pharm; 2004 Jan; 30(1):83-93. PubMed ID: 15000433
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Site specific solubility improvement using solid dispersions of HPMC-AS/HPC SSL--mixtures.
    Zecevic DE; Meier R; Daniels R; Wagner KG
    Eur J Pharm Biopharm; 2014 Jul; 87(2):264-70. PubMed ID: 24768770
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Continuous production of controlled release dosage forms based on hot-melt extruded gum arabic: Formulation development, in vitro characterization and evaluation of potential application fields.
    Kipping T; Rein H
    Int J Pharm; 2016 Jan; 497(1-2):36-53. PubMed ID: 26617317
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The use of design of experiments to develop hot melt extrudates for extended release of diclofenac sodium.
    Sanoufi MR; Aljaberi A; Hamdan I; Al-Zoubi N
    Pharm Dev Technol; 2020 Feb; 25(2):187-196. PubMed ID: 31637932
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of modified ethylcellulose lattices for microporous coating of osmotic tablets.
    Appel LE; Zentner GM
    Pharm Res; 1991 May; 8(5):600-4. PubMed ID: 1866374
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Controlled-release naproxen using micronized ethyl cellulose by wet-granulation and solid-dispersion method.
    Iqbal Z; Babar A; Ashraf M
    Drug Dev Ind Pharm; 2002; 28(2):129-34. PubMed ID: 11926356
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Co-extrusion as manufacturing technique for multilayer mini-matrices with dual drug release.
    Dierickx L; Remon JP; Vervaet C
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1157-63. PubMed ID: 23422733
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Studying the factors that impact the dissolution characteristic of complex drug product.
    Babayeva M; Marfo AA; Wolfe R; Hlaing YCS; Loewy ZG; Selvi BA
    Pharm Dev Technol; 2019 Dec; 24(10):1200-1209. PubMed ID: 31343377
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of drying technique on extrusion-spheronisation granules and tablet properties.
    Song B; Rough SL; Wilson DI
    Int J Pharm; 2007 Mar; 332(1-2):38-44. PubMed ID: 17071030
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Preparation and evaluation of enteric coated tablets of hot-melt extruded lansoprazole.
    Alsulays BB; Kulkarni V; Alshehri SM; Almutairy BK; Ashour EA; Morott JT; Alshetaili AS; Park JB; Tiwari RV; Repka MA
    Drug Dev Ind Pharm; 2017 May; 43(5):789-796. PubMed ID: 27486807
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Biopharmaceutical evaluation of a tablet dosage form made from ethyl cellulose encapsulated aspirin particles.
    Zia H; Falamarzian M; Raisi A; Montaseri H; Needham TE
    J Microencapsul; 1991; 8(1):21-8. PubMed ID: 1880688
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The Development of Direct Extrusion-Injection Moulded Zein Matrices as Novel Oral Controlled Drug Delivery Systems.
    Bouman J; Belton P; Venema P; van der Linden E; de Vries R; Qi S
    Pharm Res; 2015 Aug; 32(8):2775-86. PubMed ID: 25777612
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Evaluation of hot-melt extrusion technique in the preparation of HPC matrices for prolonged release.
    Loreti G; Maroni A; Del Curto MD; Melocchi A; Gazzaniga A; Zema L
    Eur J Pharm Sci; 2014 Feb; 52():77-85. PubMed ID: 24211649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.